Growth hormone secretagogues: history, mechanism of action, and clinical development
This article explains the gastrointestinal effects of GLP-1 therapy and provides practical guidance for managing bowel changes during treatment
In February 2024, at least 55 lawsuits were consolidated into a federal multidistrict lawsuit (MDL) in eastern Pennsylvania
If symptoms are troublesome, your doctor may, after individual assessment, suggest: pausing dose increases for a period in some cases, temporarily reducing the dose Adjusting the dose does not mean treatment has failed
Laboratory investigation typically includes comprehensive metabolic panel, magnesium level, creatine kinase (if muscle injury is suspected), and possibly vitamin D level
Moreover, the combination of etomidate in ECT and Fer-1 exhibited a stronger antidepressant effect compared to etomidate in ECT alone (Li et al., 2023)